Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Cabrera

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Marine Drugs|July 25, 2022
Sulfated Polysaccharide Extracted from the Green Algae <i>Codium bernabei</i>: Physicochemical Characterization and Antioxidant, Anticoagulant and Antitumor ActivityFabian A Figueroa, Roberto T Abdala-Díaz, Claudia Pérez, et al.
Computational Biology and Chemistry|July 24, 2023
Ugi efficient synthesis of novel N-alkylated lipopeptides, antimicrobial properties and computational studies in Staphylococcus aureus via MurD antibacterial targetOscar Valdes, Akbar Ali, Verónica Carrasco-Sánchez, et al.
BMC Cancer|May 3, 2005
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genesPilar Zambrano, Blanca Segura-Pacheco, Enrique Perez-Cardenas, et al.
Cancer Cell International|February 2, 2006
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell linesAlma Chavez-Blanco, Carlos Perez-Plasencia, Enrique Perez-Cardenas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 18, 2011
Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot studyMartín Granados García, María Fátima Chilaca Rosas, Arturo Javier Lavín Lozano, et al.
Molecular Cancer|July 9, 2005
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I studyAlma Chavez-Blanco, Blanca Segura-Pacheco, Enrique Perez-Cardenas, et al.
Animal Reproduction|March 21, 2024
Does GnRH treatment at TAI regardless of estrus occurrence increase pregnancy rate in crossbred <i>Bos taurus</i> suckled cows?Vanessa Silva Fernandes, Gabriella Dos Santos Velho, Mateus Felipe Osório Dos Santos, et al.
Journal of Medical Genetics|March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 25, 2013
Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry RegistryDominique P Germain, Frank Weidemann, Ademola Abiose, et al.
Pediatric Nephrology (Berlin, Germany)|July 11, 2018
Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Juan Politei, Valeria Alberton, Oscar Amoreo, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Marine Drugs|July 25, 2022
Sulfated Polysaccharide Extracted from the Green Algae <i>Codium bernabei</i>: Physicochemical Characterization and Antioxidant, Anticoagulant and Antitumor ActivityFabian A Figueroa, Roberto T Abdala-Díaz, Claudia Pérez, et al.
Computational Biology and Chemistry|July 24, 2023
Ugi efficient synthesis of novel N-alkylated lipopeptides, antimicrobial properties and computational studies in Staphylococcus aureus via MurD antibacterial targetOscar Valdes, Akbar Ali, Verónica Carrasco-Sánchez, et al.
BMC Cancer|May 3, 2005
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genesPilar Zambrano, Blanca Segura-Pacheco, Enrique Perez-Cardenas, et al.
Cancer Cell International|February 2, 2006
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell linesAlma Chavez-Blanco, Carlos Perez-Plasencia, Enrique Perez-Cardenas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 18, 2011
Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot studyMartín Granados García, María Fátima Chilaca Rosas, Arturo Javier Lavín Lozano, et al.
Molecular Cancer|July 9, 2005
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I studyAlma Chavez-Blanco, Blanca Segura-Pacheco, Enrique Perez-Cardenas, et al.
Animal Reproduction|March 21, 2024
Does GnRH treatment at TAI regardless of estrus occurrence increase pregnancy rate in crossbred <i>Bos taurus</i> suckled cows?Vanessa Silva Fernandes, Gabriella Dos Santos Velho, Mateus Felipe Osório Dos Santos, et al.
Journal of Medical Genetics|March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 25, 2013
Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry RegistryDominique P Germain, Frank Weidemann, Ademola Abiose, et al.
Pediatric Nephrology (Berlin, Germany)|July 11, 2018
Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Juan Politei, Valeria Alberton, Oscar Amoreo, et al.
Pageof 10